Association of Metronidazole with Cancer: A Potential Risk . . . - PubMed Conclusion: Due to potent carcinogenic behaviour, use of MTZ for animals' treatment and its uses in animal food products is prohibited in USA and European countries; however its clinical use in human population is still increasing
Lack of Evidence for Cancer Due to Use of Metronidazole Forty cases of cancer were diagnosed in the metronidazole-exposed group during 8267 person-years of follow-up evaluation since exposure No person had a tumor in more than one site
Association of Metronidazole with Cancer: A Potential Risk Factor or . . . Conclusion: Due to potent carcinogenic behaviour, use of MTZ for animals’ treatment and its uses in animal food products is prohibited in USA and European countries; however its clinical use in human population is still increasing
Cancer After Exposure to Metronidazole The analysis of these data suggests no significant increase in cancer-related morbidity or mortality for women exposed to metronidazole for treatment of vaginal trichomoniasis
Short-Term Metronidazole not Linked to Cancer Several factors have raised concerns about metronidazole: its mutagenic activity in vitro, its carcinogenic potential in animals, and its expanded use in humans
Regular Low-Dose Oral Metronidazole Is Associated With Fewer . . . Our data indicate that there is a significant inverse association between oral maintenance metronidazole and malignant fistulae in locally recurrent cervical cancer The impact of this simple intervention on pelvic symptoms, fistulae, and survival should be evaluated in prospective studies
Clinical Trials Using Metronidazole - NCI - National Cancer Institute Review the clinical trials studying metronidazole on this list and use the filters to refine the results by age and location Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations